Colgate-Palmolive India shares fell over 2% today amid investor uncertainty regarding the company’s growth strategy. While Motilal Oswal maintains a 'Buy' rating with a ₹2,500 target following 12% revenue growth in 1QFY27, other brokerages have raised concerns over profit margins being squeezed by aggressive advertising spending.
Shares of Colgate-Palmolive India faced selling pressure on Tuesday, August 18, 2026, trading over 2% lower as investors weighed the company's recent strategic shifts against concerns about profitability. The move follows a divergence in analyst views, with some firms questioning whether heavy spending to drive sales growth is sustainable without hurting the company's bottom line.
Motilal Oswal recently maintained a 'Buy' rating on the stock with a target price of ₹2,500, pointing to the company's 1QFY27 performance. In the first quarter of fiscal year 2027, the company reported a 12% year-on-year revenue growth, reaching approximately ₹1,600 crore. This double-digit expansion—the first in six quarters—was largely driven by a mix of volume growth and a focus on premium products.
However, this growth has come at a cost. The company increased its advertising and promotion expenses by roughly 34% during the quarter. This aggressive spending strategy led to a contraction in EBITDA margins, which were reported at approximately 30.1%. While Motilal Oswal views this as a necessary investment to fuel long-term premiumization and capture rural demand, other brokerages, including Goldman Sachs and Citi, have adopted a more cautious stance.
These firms have maintained 'Sell' ratings, flagging the trade-off between growth-focused spending and operating efficiency. The core concern for investors is whether the significant increase in marketing expenditure will lead to a lasting recovery in volume growth, or if it will simply result in persistent pressure on profit margins. The company's net profit for the quarter rose by 7% year-on-year to ₹343 crore, a figure that some market participants felt lagged behind the revenue momentum due to the higher operating costs.
Beyond internal strategy, the oral care sector faces broader challenges, including intense competition and macroeconomic factors that could impact rural consumption. If raw material costs rise or if competitors match the company's advertising intensity, the company may find it difficult to maintain its current margin profile while chasing revenue targets. Investors may watch how effectively the company manages these costs in the coming quarters and whether the volume growth remains consistent without the need for such steep increases in promotional spending.